News Releases
This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
04 19 2018 - Revenues of $1.88 billion, up 3.7% from 2017Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the first quarter ended March 31, 2018. "We...
04 09 2018 One in four clinicians surveyed will disregard screening guidelines for chlamydia and/or gonorrhea if a patient is asymptomaticDespite record high rates of new cases of sexually transmitted diseases (STDs), young women who are sexually active often don't talk to their clinicians about sex and STD risk, and many aren't...
-
04 06 2018 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report first quarter 2018 results on Thursday, April 19, 2018,...
-
04 02 2018 LOUISVILLE, Ky. & NEW YORK & SECAUCUS, N.J. & MINNETONKA, Minn.--April 2, 2018--Five leading health care organizations – Humana (NYSE: HUM), MultiPlan, Quest Diagnostics (NYSE: DGX) and...
02 26 2018 Collaboration will leverage insights from Quest’s Blueprint for Athletes biometric testing service data to examine physiological changes, performance variables in competitive athletes at the newly created Quest Diagnostics Sports Science Laboratory at the Rutgers–New Brunswick Center for Health & Human PerformanceSecaucus, NJ and New Brunswick, NJ, Feb. 26, 2018 (GLOBE NEWSWIRE) -- Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, and Rutgers University–New...